Profile picture

Professor Maciej Wybraniec

School of Medicine in Katowice, Medical University of Silesia, Katowice (Poland)
Membership: FESC Member
Follow
Biography
Prof. Maciej Wybraniec is an interventional cardiologist from Medical University of Silesia in Katowice and Head of Intensive Cardiac Care Unit of Upper Silesian Medical Center in Katowice, Poland. His areas of clinical and scientific expertise are high-risk percutaneous coronary interventions, percutaneous mechanical circulatory support, acute heart failure, cardiorenal syndrome, pharmacological treatment of supraventricular and ventricular arrhythmias and cardiomyopathies. Prof. Maciej Wybraniec is the member of Club 30 of Polish Cardiac Society and currently serves as the Chief of Regional Department of Polish Cardiac Society.
Logo ESC

Contributor content

Variability of left ventricular ejection fraction in cardiovascular patients with and without heart failure
Presentation
Variability of left ventricular ejection fraction in cardiovascular patients with and without heart failure
Analysis of left atrial thrombus in atrial flutter and atrial fibrillation
Presentation
Analysis of left atrial thrombus in atrial flutter and atrial fibrillation
Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study
Presentation
Efficacy and safety of antiarrhythmic drugs for pharmacological cardioversion of atrial fibrillation depending on gender: a subanalysis of CANT II Study
Clinical characteristics and risk factors of in-hospital mortality among patients undergoing percutaneous pericardiocentesis
Presentation
Clinical characteristics and risk factors of in-hospital mortality among patients undergoing percutaneous pericardiocentesis
Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation and atrial flutter: insights from the LATTEE registry
Presentation
Heart failure and the risk of left atrial thrombus formation in patients with atrial fibrillation and atrial flutter: insights from the LATTEE registry
Pharmacological cardioversion of recent-onset atrial fibrillation in patients with chronic kidney disease: sub-analysis of the CANT Study
Presentation
Pharmacological cardioversion of recent-onset atrial fibrillation in patients with chronic kidney disease: sub-analysis of the CANT Study
CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
Presentation
CHLD score, a new score based on traditional risk factor evaluation and long-term cardiovascular outcomes in patients with systemic sclerosis
Antazoline for pharmacological cardioversion of atrial fibrillation: the results of the high-volume multicenter CANT study
Presentation
Antazoline for pharmacological cardioversion of atrial fibrillation: the results of the high-volume multicenter CANT study
Managed Care after Acute Myocardial Infarction (MC-AMI) reduces MACE by 45% in 3-month follow-up - results form Poland's National Health Fund program of post-MI care. A single center analysis
Presentation
Managed Care after Acute Myocardial Infarction (MC-AMI) reduces MACE by 45% in 3-month follow-up - results form Poland's National Health Fund program of post-MI care. A single center analysis
Efficacy of comprehensive Managed Care after Acute Myocardial Infarction (MC-AMI) in a long-term follow-up - preliminary experience of a single high-volume center.
Presentation
Efficacy of comprehensive Managed Care after Acute Myocardial Infarction (MC-AMI) in a long-term follow-up - preliminary experience of a single high-volume center.

ESC 365 is supported by